Pelvalon today announced reimbursement for the company’s Eclipse System under a new national payment established by the Centers for Medicare and Medicaid Services (CMS). The decision enables women access to a life-changing therapy for loss of bowel control, as well as the potential to reduce costs to the healthcare system compared to existing, more expensive treatments. Headquartered in Santa Clara, California, privately…
Israeli femtech company MobileODT, who are innovating in cervical cancer screening, have announced that their Visual Check AI technology is supporting a large-scale government cervical cancer screening project in the Dominican Republic. This proof of concept project was initiated as part of the company’s strategic direction in providing cervical cancer screening at scale, utilizing Artificial Intelligence (AI) and Machine Learning (ML) capabilities. The…
DotLab, a healthcare technology company at the forefront of research and development to combat women’s health conditions, today announced the initiation of EMPOWER, a multi-center cohort study for endometriosis. The EMPOWER Study is designed to support future development activities for DotLab’s non-invasive test to aid in the diagnosis of active endometriosis. Last year, DotLab announced the publication of data in the American Journal…
UVision360 announced earlier today that the U.S. Food and Drug Administration (FDA) has accepted the Company’s submission to expand the LUMINELLE DTx System portfolio to now include the LUMINELLE 360° Bx (Biopsy) Sheath. The LUMINELLE DTx System, is a compact hysteroscopy and cystoscopy system, designed to meet the needs of patients and physicians in the office setting. The novel and patented LUMINELLE…
Canada-based Utiva, whose vision is to provide best-in-class solutions to start a UTI-free life has recently annoucned the launch of its flagship line of urinary tract health and wellness supplements. The line comprises three point-of-need products: Utiva UTI Control 36PAC Cranberry Pills, D-Mannose Attack, and Probiotic Power Supplements, to serve as an effective wellness trio that can be customized and catered to your long…
Atlantic Therapeutics, the Ireland-based company pioneering a non-invasive, wearable treatment for urinary incontinence, today announced it has raised significant new investment from the Dutch Borski Fund and the Western Development Commission in Ireland. The Borski Fund addresses the venture capital gender gap through investments in female-led and femtech companies, and their support for Atlantic Therapeutics is a strong endorsement of the progress…
Ferring Pharmaceuticals, Rebiotix, a Ferring Company, and MyBiotics Pharma today announced a multi-year strategic collaboration to develop live microbiota-based biotherapeutics to address bacterial vaginosis, a common vaginal infection among women of reproductive age linked to increased risk of miscarriage and complications for pregnancy and fertility. The collaboration is an important step forward in harnessing the power of the human microbiome in this area…
Barcelona-based company MiMARK has received €1.5M in funding from EIT Health following the EIT Health Wild Card program. The company is working on improving accuracy and efficiency of diagnostics for endometrial cancer. Abnormal vaginal bleeding affects 9M women in EU and US yearly. Diagnosis of endometrial cancer is mandatory since 10% of these women will suffer it. Current diagnosis is based on the pathological…
